Global Hexadecanamide Market Insights, Forecast to 2029

Publication ID:

PB504233309

Publication Date:

June 1, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 4,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

Hexadecanamide is a fatty acid amide.
The global Hexadecanamide market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Hexadecanamide used in pharmaceutical intermediates and cosmetic additives
In terms of production side, this report researches the Hexadecanamide production, growth rate, market share by manufacturers and by region (region level and country level), from 2018 to 2023, and forecast to 2029.
In terms of consumption side, this report focuses on the sales of Hexadecanamide by region (region level and country level), by company, by Type and by Application. from 2018 to 2023 and forecast to 2029.
Report Includes:
This report presents an overview of global market for Hexadecanamide, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Hexadecanamide, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Hexadecanamide, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Hexadecanamide sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Hexadecanamide market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Hexadecanamide sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Shengrui Medicine, Hangzhou Fanda Chemical, Changzhou Kefeng, Shalong Chemical, Phosgene Chemical, Ditong Chemical and BASF, etc.
By Company
Shengrui Medicine
Hangzhou Fanda Chemical
Changzhou Kefeng
Shalong Chemical
Phosgene Chemical
Ditong Chemical
BASF
Segment by Type
Purity 95%
Purity 99%
Others
Segment by Application
Pharmaceutical Intermediates
Cosmetic Additives
Others
Production by Region
North America
Europe
China
Japan
Sales by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Hexadecanamide production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Hexadecanamide in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Hexadecanamide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 9: China by type and by application sales and revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hexadecanamide sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Study Coverage
1.1 Hexadecanamide Product Introduction
1.2 Market by Type
1.2.1 Global Hexadecanamide Market Size by Type, 2018 VS 2022 VS 2029
1.2.2 Purity 95%
1.2.3 Purity 99%
1.2.4 Others
1.3 Market by Application
1.3.1 Global Hexadecanamide Market Size by Application, 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical Intermediates
1.3.3 Cosmetic Additives
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Hexadecanamide Production
2.1 Global Hexadecanamide Production Capacity (2018-2029)
2.2 Global Hexadecanamide Production by Region: 2018 VS 2022 VS 2029
2.3 Global Hexadecanamide Production by Region
2.3.1 Global Hexadecanamide Historic Production by Region (2018-2023)
2.3.2 Global Hexadecanamide Forecasted Production by Region (2024-2029)
2.3.3 Global Hexadecanamide Production Market Share by Region (2018-2029)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Executive Summary
3.1 Global Hexadecanamide Revenue Estimates and Forecasts 2018-2029
3.2 Global Hexadecanamide Revenue by Region
3.2.1 Global Hexadecanamide Revenue by Region: 2018 VS 2022 VS 2029
3.2.2 Global Hexadecanamide Revenue by Region (2018-2023)
3.2.3 Global Hexadecanamide Revenue by Region (2024-2029)
3.2.4 Global Hexadecanamide Revenue Market Share by Region (2018-2029)
3.3 Global Hexadecanamide Sales Estimates and Forecasts 2018-2029
3.4 Global Hexadecanamide Sales by Region
3.4.1 Global Hexadecanamide Sales by Region: 2018 VS 2022 VS 2029
3.4.2 Global Hexadecanamide Sales by Region (2018-2023)
3.4.3 Global Hexadecanamide Sales by Region (2024-2029)
3.4.4 Global Hexadecanamide Sales Market Share by Region (2018-2029)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufactures
4.1 Global Hexadecanamide Sales by Manufacturers
4.1.1 Global Hexadecanamide Sales by Manufacturers (2018-2023)
4.1.2 Global Hexadecanamide Sales Market Share by Manufacturers (2018-2023)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hexadecanamide in 2022
4.2 Global Hexadecanamide Revenue by Manufacturers
4.2.1 Global Hexadecanamide Revenue by Manufacturers (2018-2023)
4.2.2 Global Hexadecanamide Revenue Market Share by Manufacturers (2018-2023)
4.2.3 Global Top 10 and Top 5 Companies by Hexadecanamide Revenue in 2022
4.3 Global Hexadecanamide Sales Price by Manufacturers
4.4 Global Key Players of Hexadecanamide, Industry Ranking, 2021 VS 2022 VS 2023
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Hexadecanamide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Hexadecanamide, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Hexadecanamide, Product Offered and Application
4.8 Global Key Manufacturers of Hexadecanamide, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Hexadecanamide Sales by Type
5.1.1 Global Hexadecanamide Historical Sales by Type (2018-2023)
5.1.2 Global Hexadecanamide Forecasted Sales by Type (2024-2029)
5.1.3 Global Hexadecanamide Sales Market Share by Type (2018-2029)
5.2 Global Hexadecanamide Revenue by Type
5.2.1 Global Hexadecanamide Historical Revenue by Type (2018-2023)
5.2.2 Global Hexadecanamide Forecasted Revenue by Type (2024-2029)
5.2.3 Global Hexadecanamide Revenue Market Share by Type (2018-2029)
5.3 Global Hexadecanamide Price by Type
5.3.1 Global Hexadecanamide Price by Type (2018-2023)
5.3.2 Global Hexadecanamide Price Forecast by Type (2024-2029)
6 Market Size by Application
6.1 Global Hexadecanamide Sales by Application
6.1.1 Global Hexadecanamide Historical Sales by Application (2018-2023)
6.1.2 Global Hexadecanamide Forecasted Sales by Application (2024-2029)
6.1.3 Global Hexadecanamide Sales Market Share by Application (2018-2029)
6.2 Global Hexadecanamide Revenue by Application
6.2.1 Global Hexadecanamide Historical Revenue by Application (2018-2023)
6.2.2 Global Hexadecanamide Forecasted Revenue by Application (2024-2029)
6.2.3 Global Hexadecanamide Revenue Market Share by Application (2018-2029)
6.3 Global Hexadecanamide Price by Application
6.3.1 Global Hexadecanamide Price by Application (2018-2023)
6.3.2 Global Hexadecanamide Price Forecast by Application (2024-2029)
7 US & Canada
7.1 US & Canada Hexadecanamide Market Size by Type
7.1.1 US & Canada Hexadecanamide Sales by Type (2018-2029)
7.1.2 US & Canada Hexadecanamide Revenue by Type (2018-2029)
7.2 US & Canada Hexadecanamide Market Size by Application
7.2.1 US & Canada Hexadecanamide Sales by Application (2018-2029)
7.2.2 US & Canada Hexadecanamide Revenue by Application (2018-2029)
7.3 US & Canada Hexadecanamide Sales by Country
7.3.1 US & Canada Hexadecanamide Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 US & Canada Hexadecanamide Sales by Country (2018-2029)
7.3.3 US & Canada Hexadecanamide Revenue by Country (2018-2029)
7.3.4 U.S.
7.3.5 Canada
8 Europe
8.1 Europe Hexadecanamide Market Size by Type
8.1.1 Europe Hexadecanamide Sales by Type (2018-2029)
8.1.2 Europe Hexadecanamide Revenue by Type (2018-2029)
8.2 Europe Hexadecanamide Market Size by Application
8.2.1 Europe Hexadecanamide Sales by Application (2018-2029)
8.2.2 Europe Hexadecanamide Revenue by Application (2018-2029)
8.3 Europe Hexadecanamide Sales by Country
8.3.1 Europe Hexadecanamide Revenue by Country: 2018 VS 2022 VS 2029
8.3.2 Europe Hexadecanamide Sales by Country (2018-2029)
8.3.3 Europe Hexadecanamide Revenue by Country (2018-2029)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Hexadecanamide Market Size by Type
9.1.1 China Hexadecanamide Sales by Type (2018-2029)
9.1.2 China Hexadecanamide Revenue by Type (2018-2029)
9.2 China Hexadecanamide Market Size by Application
9.2.1 China Hexadecanamide Sales by Application (2018-2029)
9.2.2 China Hexadecanamide Revenue by Application (2018-2029)
10 Asia (excluding China)
10.1 Asia Hexadecanamide Market Size by Type
10.1.1 Asia Hexadecanamide Sales by Type (2018-2029)
10.1.2 Asia Hexadecanamide Revenue by Type (2018-2029)
10.2 Asia Hexadecanamide Market Size by Application
10.2.1 Asia Hexadecanamide Sales by Application (2018-2029)
10.2.2 Asia Hexadecanamide Revenue by Application (2018-2029)
10.3 Asia Hexadecanamide Sales by Region
10.3.1 Asia Hexadecanamide Revenue by Region: 2018 VS 2022 VS 2029
10.3.2 Asia Hexadecanamide Revenue by Region (2018-2029)
10.3.3 Asia Hexadecanamide Sales by Region (2018-2029)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Hexadecanamide Market Size by Type
11.1.1 Middle East, Africa and Latin America Hexadecanamide Sales by Type (2018-2029)
11.1.2 Middle East, Africa and Latin America Hexadecanamide Revenue by Type (2018-2029)
11.2 Middle East, Africa and Latin America Hexadecanamide Market Size by Application
11.2.1 Middle East, Africa and Latin America Hexadecanamide Sales by Application (2018-2029)
11.2.2 Middle East, Africa and Latin America Hexadecanamide Revenue by Application (2018-2029)
11.3 Middle East, Africa and Latin America Hexadecanamide Sales by Country
11.3.1 Middle East, Africa and Latin America Hexadecanamide Revenue by Country: 2018 VS 2022 VS 2029
11.3.2 Middle East, Africa and Latin America Hexadecanamide Revenue by Country (2018-2029)
11.3.3 Middle East, Africa and Latin America Hexadecanamide Sales by Country (2018-2029)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profiles
12.1 Shengrui Medicine
12.1.1 Shengrui Medicine Company Information
12.1.2 Shengrui Medicine Overview
12.1.3 Shengrui Medicine Hexadecanamide Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.1.4 Shengrui Medicine Hexadecanamide Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Shengrui Medicine Recent Developments
12.2 Hangzhou Fanda Chemical
12.2.1 Hangzhou Fanda Chemical Company Information
12.2.2 Hangzhou Fanda Chemical Overview
12.2.3 Hangzhou Fanda Chemical Hexadecanamide Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.2.4 Hangzhou Fanda Chemical Hexadecanamide Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Hangzhou Fanda Chemical Recent Developments
12.3 Changzhou Kefeng
12.3.1 Changzhou Kefeng Company Information
12.3.2 Changzhou Kefeng Overview
12.3.3 Changzhou Kefeng Hexadecanamide Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.3.4 Changzhou Kefeng Hexadecanamide Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Changzhou Kefeng Recent Developments
12.4 Shalong Chemical
12.4.1 Shalong Chemical Company Information
12.4.2 Shalong Chemical Overview
12.4.3 Shalong Chemical Hexadecanamide Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.4.4 Shalong Chemical Hexadecanamide Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Shalong Chemical Recent Developments
12.5 Phosgene Chemical
12.5.1 Phosgene Chemical Company Information
12.5.2 Phosgene Chemical Overview
12.5.3 Phosgene Chemical Hexadecanamide Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.5.4 Phosgene Chemical Hexadecanamide Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Phosgene Chemical Recent Developments
12.6 Ditong Chemical
12.6.1 Ditong Chemical Company Information
12.6.2 Ditong Chemical Overview
12.6.3 Ditong Chemical Hexadecanamide Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.6.4 Ditong Chemical Hexadecanamide Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Ditong Chemical Recent Developments
12.7 BASF
12.7.1 BASF Company Information
12.7.2 BASF Overview
12.7.3 BASF Hexadecanamide Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.7.4 BASF Hexadecanamide Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 BASF Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Hexadecanamide Industry Chain Analysis
13.2 Hexadecanamide Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Hexadecanamide Production Mode & Process
13.4 Hexadecanamide Sales and Marketing
13.4.1 Hexadecanamide Sales Channels
13.4.2 Hexadecanamide Distributors
13.5 Hexadecanamide Customers
14 Hexadecanamide Market Dynamics
14.1 Hexadecanamide Industry Trends
14.2 Hexadecanamide Market Drivers
14.3 Hexadecanamide Market Challenges
14.4 Hexadecanamide Market Restraints
15 Key Finding in The Global Hexadecanamide Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

Companies Mentioned:

Shengrui Medicine
Hangzhou Fanda Chemical
Changzhou Kefeng
Shalong Chemical
Phosgene Chemical
Ditong Chemical
BASF

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂